ETK-1 Cells
USD$550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | ETK-1 is a human intrahepatic cholangiocarcinoma (IHCCA) cell line originally established from the ascitic fluid of an adult patient with sarcomatoid cholangiocarcinoma. The tumor from which ETK-1 was derived exhibited both tubular adenocarcinoma and sarcomatoid components, and the cell line reflects the sarcomatoid phenotype. ETK-1 cells grow adherently as a uniform epithelial monolayer with a cobblestone appearance, composed mainly of small polygonal cells with round to oval nuclei and prominent nucleoli. Early passage cells demonstrated a population doubling time of approximately 70 hours and a hyperdiploid karyotype with a modal chromosome number in the mid-70s, consistent with chromosomal instability typical of aggressive biliary tract malignancies. Immunophenotypically, ETK-1 cells express biliary epithelial markers including γ-glutamyl transpeptidase (GGT), cytokeratin 18 (CK18), and cytokeratin 19 (CK19), confirming their cholangiocytic origin. They are negative for hepatocyte-associated markers such as alpha-fetoprotein (AFP) and albumin under basal conditions. ETK-1 cells express vimentin, reflecting their sarcomatoid characteristics and partial mesenchymal phenotype, while lacking expression of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9). This marker profile corresponds to the sarcomatoid component observed in the primary tumor and highlights features consistent with epithelial-mesenchymal transition-like properties. ETK-1 has also been used as a model to study cellular plasticity and lineage differentiation in cholangiocarcinoma. Treatment with the DNA methyltransferase inhibitor 5-azacytidine induced morphological and phenotypic changes, resulting in a derivative cell line with hepatocyte-like features, including expression of AFP, albumin, integrin α1, and thrombopoietin, along with loss of certain biliary markers. In xenograft models, untreated ETK-1 cells form tumors consistent with tubular adenocarcinoma displaying a ductal phenotype. These findings demonstrate that ETK-1 retains differentiation plasticity and serves as a valuable in vitro system for investigating biliary epithelial-to-hepatocytic transdifferentiation, epigenetic regulation, and tumor heterogeneity in intrahepatic cholangiocarcinoma. |
|---|---|
| Organism | Human |
| Tissue | Metastatic |
| Disease | Cholangiocarcinoma |
| Metastatic site | Ascites |
| Synonyms | ETK1 |
Characteristics
| Age | 61 years |
|---|---|
| Gender | Female |
| Ethnicity | Japanese |
| Growth properties | Adherent |
Regulatory Data
| Citation | ETK-1 (Cytion catalog number 305529) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1206 |
Biomolecular Data
| Mutational profile | Mutation: p.Arg175His, Homozygous |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase, 5 min., 37°C |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 to 3 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Metastatic site: | Ascites |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305529-260526 | Certificate of Analysis | 13. Jul. 2026 | 305529 |